Evidence map›Paper›PMID 23979522›Full record

ArticleLeukemia2014

Overexpression of SNORD114-3 marks acute promyelocytic leukemia.

T Liuksiala, K J Teittinen, K Granberg, M Heinäniemi, M Annala, M Mäki, M Nykter, O Lohi

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Leukemia, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Review
  3. Small nucleolar RNAs: the hidden precursors of cancer ribosomes.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2025
    Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. DNA methylation signatures in cord blood of ICSI children.Human reproduction (Oxford, England) · 2017
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

T Liuksiala1] Institute of Biomedical Technology, University of Tampere, Tampere, Finland [2] Department of Signal Processing, Tampere University of Technology, Tampere, Finland.
K J TeittinenTampere Center for Child Health Research, University of Tampere and Tampere University Hospital, Tampere, Finland.
K Granberg1] Institute of Biomedical Technology, University of Tampere, Tampere, Finland [2] Department of Signal Processing, Tampere University of Technology, Tampere, Finland.
M HeinäniemiA.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
M Annala1] Institute of Biomedical Technology, University of Tampere, Tampere, Finland [2] Department of Signal Processing, Tampere University of Technology, Tampere, Finland.
M MäkiTampere Center for Child Health Research, University of Tampere and Tampere University Hospital, Tampere, Finland.
M Nykter1] Institute of Biomedical Technology, University of Tampere, Tampere, Finland [2] BioMediTech, Tampere, Finland.
O LohiTampere Center for Child Health Research, University of Tampere and Tampere University Hospital, Tampere, Finland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Gene Expression ProfilingBiomarkers, TumorHumansLeukemia, Myeloid, AcuteLeukemia, Promyelocytic, AcuteRNA, Small NucleolarBiomarkers, TumorRNA, Small Nucleolar

Identifiers

PMID23979522

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.